Prime Bank Securities Limited has selected 10 blue-chip companies listed on the Dhaka Stock Exchange (DSE) with strong dividend yields and earnings growth potential, based on their financial performance in the July-September quarter of 2026.
According to a research note prepared by the brokerage’s research desk using closing share prices as of 18 November, Square Pharmaceuticals topped the list, followed by Jamuna Bank, BSRM Steels, BRAC Bank, Beximco Pharmaceuticals, Berger Paints Bangladesh, Robi Axiata, The ACME Laboratories, The IBN SINA Pharmaceutical Industry and Eastern Bank.
The 10 companies recorded median year-on-year earnings per share (EPS) growth of 10.7% in the quarter, with all posting higher profits than a year earlier. Their average dividend yield stood at 5.8%, while the average price-to-earnings (P/E) ratio was 8 and return on equity (ROE) was 17.6%.
Pharmaceutical companies dominated the selection with four entries, followed by three banks. Engineering, paints and telecommunications had one representative each.
Square Pharmaceuticals ranked first, trading at a P/E ratio of 6.6, with an ROE of 18.5%, a dividend yield of 6.2% and quarterly EPS growth of 5%.
Jamuna Bank came second, offering the highest dividend yield at 11.8% and ROE at 24.8%, alongside 15.9% EPS growth and a P/E ratio of 3.5. BSRM Steels ranked third after its quarterly EPS surged 115% year-on-year to Tk5.60, with a dividend yield of 6.3%.
BRAC Bank ranked fourth, posting 19.5% EPS growth and 20.3% ROE, while Beximco Pharmaceuticals came fifth with 8.3% net profit growth and a P/E ratio of 7.2.
Berger Paints Bangladesh ranked sixth with 22.1% EPS growth. It was followed by Robi Axiata, with 3.7% profit growth and a 5.9% dividend yield; ACME Laboratories, with 13% EPS growth and a P/E ratio of 6.2; and IBN SINA Pharma, with 8.2% EPS growth.
Eastern Bank completed the list, offering a 10.5% dividend yield and a P/E ratio of 4.4, despite quarterly EPS growth of just 0.7%.
The brokerage noted that banking stocks offered attractive valuations and high ROE, with Jamuna Bank leading in cash dividend yield, while ACME Laboratories added value to the pharmaceutical segment.
